Despite the fact that all patients with TAM acquire GATA1 mutations, it has been estimated that up to two-thirds remain asymptomatic (i.e., silent TAM), whereas the remaining one-third (∼10% of newborns with DS) develop clinical TAM (Roberts et al. 2013; Swerdlow et al. 2017). Here, GATA1 is linked to Dravet syndrome.